Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Campbell Soup Company (CPB): Soup Anyone? – General Mills, Inc. (GIS), Kraft Foods Group Inc (KRFT)

Page 1 of 2

Berkshire Hathaway’s recent $28 billion H.J Heinz acquisition threw the spotlight on a few food companies, one of them being Campbell Soup Company (NYSE:CPB). The day the acquisition was announced, its shares rose 6% and are nowtrading at the higher end of the 52-week range, near the high of $42.

Campbell Soup Company (NYSE:CPB)History and turnaround strategies:

  • Campbell Soup Company (NYSE:CPB), with its iconic red-and-white packaging and popular soups such as Tomato and Cream of Chicken, was a well-known household brand until it began to lose its market share in the last few years. It market share dipped to 46% vs. 51% in 2007, one of the main reason being its ill-advised move into low-sodium formulations.
  • When Denise Morrison took over in 2010 as CEO, she made the right decision to change the focus towards healthy products, fresh food and easy-to-prepare items. She focused on three main strategies : 1) Stabilize and then profitably grow North America soup and simple meals; 2) Expand the company’s international presence; and 3) Continue to drive growth in healthy beverages and baked snacks.
  • At the recent annual Consumer Analyst Group of New York (CAGNY), the Company announced that it has made significant progress and has been able to stabilize its Soup and Simple Meals business. This was corroborated by its strong 2H13 results as the segment rebounded with sales increasing 2% and EBIT increasing 7%. This was mainly due to increased focus on re-engaging the consumer and innovation and the Company has mentioned that it will continue to focus on innovation introducing more than 50 new products by Aug 2013, up from only 3 in 2010 and 2011.
  • With an intention to increase its international expansion,  on 14th Feb it announced an arrangement with Grupo Jumex and Conservas La Costeña that will help expand the companys access to manufacturing and distribution capabilities in Mexico. As a result of these agreements, Campbell will close its plant in Villagrán, Mexico, and recorded a restructuring charge of $6 million in 2Q13.
  • Further, in line with its strategy the company also acquired Bolthouse Farms in July 2012, the manufacturer of healthy food products. The acquisition has given it access to $12 billion packaged fresh foods market as well as  complements its existing V8 business beverage. For 2H13, Bolthouse contributed $195 million (8%) to total sales and $15 million (2%) to operating income. Company guided that it will contribute ~$750 million to sales and add $0.05 to $0.07 to adjusted EPS in FY13.

Financial performance:

  • On Feb. 15, Campbell announced its 2Q13 results, sales were up 10% due to 1% organic growth and 9% from its Bolthouse acquisition.
  • It reaffirmed its FY13 guidance: Sales growth of 10-12% with adjusted EBIT growth of 4-6% and adjusted EPS growth of 3-5% ($2.51 and $2.57).
  • The most important factor for Campbell is its shareholder friendly policy. It has consistently maintained a dividend payout ratio of 46% in the last 4-years (in 2008 it had a dividend payout ratio of 28% due to economic recession). Further, it also an excellent share repurchase program in place. Despite these positives, the Company’s share price remains range-bound between $30-$40, ever since the recession and hence I am of the opinion, that it is only a matter of time, before the shares start moving upwards.
Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!